Alternative Marketing
PRA provides customized alternative monitoring services aligned with the FDA Clinical Trials Transformation Initiative’s and the EMA’s recommendations. Read More
Biomarkers and Diagnostic Research
PRA’s range of services also extends to cover the complex activities of IVD diagnostic and biomarker research. We understand the importance of identification of high-volume sites, robust sample integrity and rapid seamless sample processing. Read More
PRA is poised to help our clients capitalize on opportunities in the rapidly emerging biosimilar space. Our strong background in biologics/monoclonal antibodies affords us a thorough understanding of the challenges and success factors involved in biologic and biosimilar drug development. Read More
Emerging Markets
Emerging markets are of significant importance to biotech and pharmaceutical companies for their drug development programs. Read More
Tailored Partnering Solutions
An important element of any partnering process is the assessment of the overall strategic “fit” of parties. PRA has been designing and executing customized partnering models for almost 15 years. Read More
